✦ LIBER ✦

FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia

✍ Scribed by G. Specchia; D. Pastore; P. Carluccio; A. Liso; A. Mestice; R. Rizzi; L. Ciuffreda; G. Pietrantuono; V. Liso

Publisher: Springer
Year: 2005
Tongue: English
Weight: 81 KB
Volume: 84
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-005-1090-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FLAG-IDA in the treatment of refractory/

FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience

✍ D. Pastore; G. Specchia; P. Carluccio; A. Liso; A. Mestice; R. Rizzi; G. Greco; 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 116 KB

Feasibility of FLAG-IDA regimen in cases

Feasibility of FLAG-IDA regimen in cases with relapsed/refractory acute leukemia cases

✍ Semra Paydas; Sinan Yavuz; Umut Disel 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 36 KB

Treatment of relapsed or refractory adul

Treatment of relapsed or refractory adult acute lymphocytic leukemia

✍ Mathias Freund; Helmut Diedrich; Arnold Gamer; Martin Gramatzki; Gerhard Heil; A 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

Impact of reinduction regimens for relap

Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults

✍ Dr. Jeanna L. Welborn 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB 👁 2 views

## Abstract The clinical outlook for adults with acute lymphoblastic leukemia (ALL) has Improved with the use of intensive chemotherapy. Complete remissions (CR) are achieved in 80% of adults but the majority relapse on maintenance chemotherapy and a few exhibit primary resistance to induction ther

Primary refractory and relapsed adult ac

Primary refractory and relapsed adult acute lymphoblastic leukemia : Characteristics, treatment results, and prognosis with salvage therapy

✍ Deborah A. Thomas; Hagop Kantarjian; Terry L. Smith; Charles Koller; Jorge Corte 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## BACKGROUND. Relapses continue to be problematic for adults with acute lymphoblastic leukemia (ALL). New therapies generally are first tested in the salvage setting prior to incorporation into frontline regimens. Defining the prognosis at relapse (or at failure of induction) and subsequently pre

Treatment of acute lymphoblastic leukemi

Treatment of acute lymphoblastic leukemia in adults

✍ Prof. Tiziano Barbui; Renato Bassan; Teodoro Chisesi; Raffaele Battista; Sergio 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie